Prevalence of metabolic syndrome among apparently healthy adults in Ogun state, Nigeria

Abstract

Purpose There is a global increase in the prevalence of metabolic syndrome (MetS) with relative paucity of data on the burden of this syndrome in developing countries like Nigeria. This study evaluated the prevalence of MetS among apparently healthy subjects in Nigeria. Design/methodology/approach A population-based cross-sectional study was conducted with 550 (249 men, 301 women) healthy subjects recruited using multi-stage technique. Anthropometric measurements were taken using standard procedures and instruments. Systolic and diastolic blood pressure was measured in all the subjects. Blood samples were collected from selected subjects and analyzed for hematological variables. Findings The prevalence of MetS was 36.8 per cent using the IDF criteria and 34.6 per cent using the NCEP-ATP III criteria. In all, 1.64 per cent (9) of respondents were underweight, 22.55 per cent (124) were of normal body mass index, 49.64 per cent (273) were overweight and 26.17 per cent (144) were obese. The mean waist circumference and waist to hip ratio for male and female were 83.27 ± 2.6 cm and 0.84 ± 0.1 and 86.22 ± 13.9 cm and 0.84 ± 0.1, respectively. Total cholesterol was elevated in 16.04 per cent of the respondents, low high-density lipoprotein cholesterol was observed in 41.83 per cent of the respondents. High values of triglycerides were observed in 5.79 per cent of respondents. Elevated low-density lipoprotein cholesterol was observed in 40.85 per cent of the respondents. This study showed that a huge burden of MetS exists among the study population. Research limitations/implications The cross-sectional design of this study limits inference regarding causality and effects. Also, there was no controlled case in the study. Practical implications There is the need for accurate knowledge of the MetS of the population to inform public health policy for mitigation. Social implications MetS has been described as a global time bomb, with a quarter of the world’s adults estimated to be having the condition. It will place a burden on social services if a lot of working population are forced to retire early due to MetS. Originality/value The findings are pointers to the probable magnitude of the co-morbid factors of cardiovascular diseases as encapsulated in the MetS in our environment.

Assessment of Cardiometabolic Risk Factors: the Case of Ethiopian Public Health Institute Staff Members

“…Our result was fairly comparable to study conducted in systematic review of Madagascar (27.7%), Nigeria (28.1%), Spain (24.3%), South Asia (29.8%), and Australia (30.7%) based on IDF criteria (39)(40)(41)(42)(43). The prevalence of metabolic syndrome in our study was less than from other studies conducted in Kenya among urban population (34.6%), Nigeria among apparently healthy adults in Ogun state (36.8%), among Turkey adults (44%), among Jourdan adults (51%) (34,(44)(45)(46). Differences in the age of study subjects, sample size, socioeconomic status, residence & lifestyle, dietary intake, and physical activity may contribute to the different prevalence of metabolic syndrome in these different studies.…”

Metabolic Syndrome and Its Association with Nutritional and Cardiometabolic Risk Factors: Prevalence among Apparently Healthy Adults in a Rural Community in Southwestern Nigeria

“…In this study, the prevalence of metabolic syndrome was 30 [10,30,35,36], The prevalence in this study, though conducted in a rural area, was similar to those obtained from studies done in urban communities. The probable reason for this may be due to its proximity to big cities and the effects of urbanization.…”

The influence of green coffee bean extract supplementation on blood glucose levels: A systematic review and dose–response meta‐analysis of randomized controlled trials

“…Therefore, reducing elevated blood glucose concentrations is a principal aim in the amelioration and management of chronic metabolic disorders (Rizza, 2010). Postprandial hyperglycemia is a prominent risk factor for metabolic syndrome (Adeyemi et al, 2017); although medicinal therapeutic strategies, such as insulin and hypoglycemic drugs, have accomplished some success in treatment, pharmacological interventions possess well-known adverse side effects (Scheen, 2005).…”